These results suggest that the role of NF90 in stabilizing VEGF during cancer-induced hypoxia might be the result of NF90 interfering with Ago2 binding to VEGF mRNA and, consequently, reduced targeting of VEGF mRNA by RISC activity. This evidence concerns the gene AGO2 and cancer.